Close Menu

diabetes

In Science this week: blood transcriptome analysis of type 1 diabetes, and more.

Investigators identified natural killer cell-related expression signatures in blood samples from children who later developed type 1 diabetes or islet autoimmunity.

The company is studying hibernating animals to see if their genomes contain novel biological pathways that could be exploited to counteract complex human diseases.

Polynesian ancestry — encompassing genetic and lifestyle factors — affects obesity, type 2 diabetes, and heart failure among Native Hawaiians, a new study has found.

By uncovering genetic factors behind blood and urine biomarkers, researchers came up with polygenic scores related to biomarker status and related disease risk.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

The companies are currently working together to commercialize their respective products including genetic tests for type 2 diabetes and gestational diabetes risk.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

A Lund University-led team developed two methylation risk scores to predict which patients would or would not respond to treatment and experience side effects.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.